NIACINAMIDE 4% / SPIRONOLACTONE 5% gel

Country: Сједињене Америчке Државе

Језик: Енглески

Извор: NLM (National Library of Medicine)

Купи Сада

Активни састојак:

NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4), SPIRONOLACTONE (UNII: 27O7W4T232) (SPIRONOLACTONE - UNII:27O7W4T232)

Доступно од:

Sincerus Florida, LLC

Пут администрације:

TOPICAL

Тип рецептора:

PRESCRIPTION DRUG

Статус ауторизације:

unapproved drug other

Карактеристике производа

                                NIACINAMIDE 4% / SPIRONOLACTONE 5%- NIACINAMIDE 4% / SPIRONOLACTONE 5%
GEL
SINCERUS FLORIDA, LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
NIACINAMIDE 4% / SPIRONOLACTONE 5%
DIRECTIONS FOR USE
SINCERUS FLORIDA, LLC. ADVERSE REACTIONS
ACTIVE, INACTIVE
NDC 72934-1157-2 NIACINAMIDE USP 4% / SPIRONOLACTONE USP 5%. GEL 30GM.
NIACINAMIDE 4% / SPIRONOLACTONE 5%
niacinamide 4 % / spironolactone 5% gel
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:729 34-1157
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
NIACINAMIDE (UNII: 25X51I8 RD4) (NIACINAMIDE - UNII:25X51I8 RD4)
NIACINAMIDE
4 g in 10 0 g
SPIRO NO LACTO NE (UNII: 27O7W4T232) (SPIRONOLACTONE -
UNII:27O7W4T232)
SPIRONOLACTONE
5 g in 10 0 g
Sincerus Florida, LLC
PRODUCT CHARACTERISTICS
COLOR
white
S CORE
S HAP E
S IZ E
FLAVOR
IMPRINT CODE
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END DATE
1
NDC:729 34-1157-
2
30 g in 1 BOTTLE, PUMP; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/10 /20 19
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/10 /20 19
LABELER -
Sincerus Florida, LLC (080105003)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Sincerus Flo rida, LLC
0 8 0 10 50 0 3
ma nufa c ture (729 34-1157)
Revised: 5/2019
                                
                                Прочитајте комплетан документ
                                
                            

Обавештења о претрази у вези са овим производом

Погледајте историју докумената